Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels.
about
The adrenergic system in pulmonary arterial hypertension: bench to bedside (2013 Grover Conference series)Right ventricular adaptation and failure in pulmonary arterial hypertension.Treatment-related biomarkers in pulmonary hypertensionEmerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial HypertensionCardiomyocyte-specific overexpression of HEXIM1 prevents right ventricular hypertrophy in hypoxia-induced pulmonary hypertension in miceImpact of Superoxide Dismutase Mimetic AEOL 10150 on the Endothelin System of Fischer 344 RatsThe right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.The right ventricle: biologic insights and response to diseaseKidney dysfunction in patients with pulmonary arterial hypertensionCurrent management of patients with pulmonary hypertension and right ventricular insufficiency.Circulating levels of copeptin predict outcome in patients with pulmonary arterial hypertension.Prognostic importance of hyponatremia in patients with acute pulmonary embolism.Pulmonary hypertension and the right ventricle-thinking outside the box (Third International Right Heart Failure Summit, part 1).Endothelin-1 and endothelial nitric oxide polymorphisms in idiopathic pulmonary arterial hypertensionPlasma volume and outcome in pulmonary hypertension.Endothelin.The endothelin system in pulmonary hypertension.Urinary cGMP concentrations in severe primary pulmonary hypertension.GRK2-mediated inhibition of adrenergic and dopaminergic signaling in right ventricular hypertrophy: therapeutic implications in pulmonary hypertension.Effects of Single Drug and Combined Short-term Administration of Sildenafil, Pimobendan, and Nicorandil on Right Ventricular Function in Rats With Monocrotaline-induced Pulmonary Hypertension.Endothelin-1 Predicts Hemodynamically Assessed Pulmonary Arterial Hypertension in HIV Infection.A review of pulmonary arterial hypertension: role of ambrisentan.Pulmonary hypertension, right ventricular failure, and kidney: different from left ventricular failure?QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension.Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial HypertensionDual ET(A)/ET(B) vs. selective ET(A) endothelin receptor antagonism in patients with pulmonary hypertension.Current treatment options in children with pulmonary arterial hypertension and experiences with oral bosentan.Novel therapeutic approaches to preserve the right ventricle.The right ventricle: biologic insights and response to disease: updated.Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension.Inhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter?Role of vasopressin and aldosterone in pulmonary arterial hypertension: A pilot study.Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertensionAmbrisentan, an endothelin receptor type A-selective endothelin receptor antagonist, for the treatment of pulmonary arterial hypertension.Ambrisentan for the treatment of pulmonary arterial hypertensionEndothelin antagonists in hypertension and kidney disease.Neurohormonal axis in patients with pulmonary arterial hypertension: friend or foe?The untapped potential of proteomic analysis in pediatric pulmonary hypertension.Adaptive capacity of the right ventricle: why does it fail?Sympathetic nervous system activation and β-adrenoceptor blockade in right heart failure.
P2860
Q26781681-5559AFA0-F50E-4AD7-A560-716B1F744836Q27318422-772DBCD5-3BA6-42C8-BED2-AB3E22B3D9EAQ28081276-812E0861-6F4F-46E8-B579-E4C04E60720AQ28085007-018EFE47-FEDB-48E5-B080-D62CB0D4B98BQ28484674-D38F53E4-5B76-4415-8AC1-1E57D42563DBQ28550890-1FE791D9-1C8F-4BD4-84E8-5B05AF4264FFQ30585014-D15EF21D-E900-4DF6-95DC-2BA45D47FF26Q33578032-FD03E5AE-34FC-4B98-BC81-9394037D98DFQ33738621-4E46DCA2-B276-44F9-88B2-AD3AB4F525AFQ34027507-C3262232-487F-41FB-B19A-25BCDC1D7DF2Q34248479-259D7180-C41B-4E7B-8A49-2C07EA31E66BQ34402419-8A8D35D2-DD73-4486-8CB4-E912E16EA000Q34782622-0809597B-F946-4F2D-93B7-47D805EC833AQ34793954-33FD0379-FFFC-496C-9C81-23EDC0263D07Q34796843-8535C15D-59CA-451A-85B0-591B2C6F4185Q35120667-8D8EAC67-BEDB-49AC-8EB8-0CB197E7D328Q35168404-6976C655-99DC-4CCB-9DDF-06B589EBE983Q35532224-2D42FFEA-08F9-43A8-A613-CD243A522F7EQ35694915-FD7615E6-FA7F-4658-985D-554C8A9C2870Q35705494-B1847C7A-1969-43FB-A0EA-30DEA14D1522Q35890439-4C92A361-2831-4013-965D-5B73FA2C2E31Q36013161-DFE4CD69-8657-4700-86FA-5DF1BA9E0298Q36063303-7357D0DF-E3A8-4CB8-86F0-DFDD5BE13051Q36075721-7924DFAC-E477-418C-9363-6E842AC02C1DQ36516814-92E6CE27-206F-441A-87D1-2C8E603D7012Q36570839-9B1B4700-2DC9-4F9A-8DE7-7E2CBF1DEFDEQ36570843-9EF0F4F6-80C9-4B5E-B32A-CCD16139284CQ36619235-00D74B05-57DB-4DE3-B5A8-14D3BE0F131FQ36644859-99C1313A-03B7-41CC-8423-B43F5FE4BBFEQ36718655-E86D471D-AF57-41EF-B61A-9391AEFF7B91Q36836706-65D51B62-AB8B-43C4-A1A8-4382B969AA33Q37308522-8E0C987B-AAAE-42BE-B034-46F36B5941B8Q37408132-8A87F76F-F893-41DD-9452-8FBC67D9CDB7Q37550525-9296DE51-B41A-47AF-B6CC-A791D8286BDCQ37634323-7750BD70-1144-40FB-B127-4D0A2EE9D2C6Q38052428-6B4BCD29-D0C3-4AA0-821B-3176BF514DD8Q38059198-4667E829-0638-4FC7-8717-5E5FBC9B4689Q38263034-910C3F22-6B01-4FE2-B15C-84DFFA8AD83EQ38355368-B1E6E5BF-DC08-44C2-A864-104E2B3CBF5FQ38364054-3A8EBA61-3F98-43D7-B019-FF135C7B9DCC
P2860
Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Neurohormonal activation in pa ...... riables and endothelin levels.
@en
Neurohormonal activation in pa ...... riables and endothelin levels.
@nl
type
label
Neurohormonal activation in pa ...... riables and endothelin levels.
@en
Neurohormonal activation in pa ...... riables and endothelin levels.
@nl
prefLabel
Neurohormonal activation in pa ...... riables and endothelin levels.
@en
Neurohormonal activation in pa ...... riables and endothelin levels.
@nl
P2093
P1476
Neurohormonal activation in pa ...... riables and endothelin levels.
@en
P2093
Francis GS
Kaufmann E
P304
P356
10.1016/0735-1097(95)00399-1
P407
P577
1995-12-01T00:00:00Z